{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T07:56:39Z","timestamp":1791618999256,"version":"4.3.4"},"reference-count":37,"publisher":"Japanese Society of Internal Medicine","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2026,1,15]]},"DOI":"10.2169\/internalmedicine.5421-25","type":"journal-article","created":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T18:08:46Z","timestamp":1751479726000},"page":"331-336","source":"Crossref","is-referenced-by-count":2,"title":["Secondary Pulmonary Alveolar Proteinosis Complicated by Hemophagocytic Syndrome in a Patient with Adult-onset Still's disease: A Case-based Review"],"prefix":"10.2169","volume":"65","author":[{"given":"Tokio","family":"Katakura","sequence":"first","affiliation":[{"name":"Department of Rheumatology, Tohoku University Hospital Sendai, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsuyoshi","family":"Shirai","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Tohoku University Hospital Sendai, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusho","family":"Ishii","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Tohoku University Hospital Sendai, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroko","family":"Sato","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Tohoku University Hospital Sendai, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuri","family":"Yamamoto","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Tohoku University Graduate School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koji","family":"Murakami","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Tohoku University Graduate School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsuyoshi","family":"Miura","sequence":"additional","affiliation":[{"name":"Department of Pathology, Tohoku University Hospital Sendai, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Fujii","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Tohoku University Hospital Sendai, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"publisher","unstructured":"1. Jouneau S, M\u00e9nard C, Lederlin M. Pulmonary alveolar proteinosis. Respirology 25: 816-826, 2020.","DOI":"10.1111\/resp.13831"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Seymour JF, Presneill JJ. Pulmonary alveolar proteinosis: progress in the first 44 years. Am J Respir Crit Care Med 166: 215-235, 2002.","DOI":"10.1164\/rccm.2109105"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Tazawa R, Ueda T, Abe M, et al. Inhaled GM-CSF for pulmonary alveolar proteinosis. N Engl J Med 381: 923-932, 2019.","DOI":"10.1056\/NEJMoa1816216"},{"key":"4","unstructured":"4. The Japanese Respiratory Society. The JRS Clinical Practice Guideline for Pulmonary Alveolar Proteinosis 2022. 1st ed. Medical Review, Tokyo, 2022 (in Japanese)."},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Filipovich AH. Hemophagocytic lymphohistiocytosis (HLH) and related disorders. Hematology Am Soc Hematol Educ Program 2009: 127-131, 2009.","DOI":"10.1182\/asheducation-2009.1.127"},{"key":"6","unstructured":"6. Yamaguchi M, Ohta A, Tsunematsu T, et al. Preliminary criteria for classification of adult Still&apos;s disease. J Rheumatol 19: 424-430, 1992."},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. McCarthy C, Bonella F, O&apos;Callaghan M, et al. European Respiratory Society guidelines for the diagnosis and management of pulmonary alveolar proteinosis. Eur Respir J 64: 2400725, 2024.","DOI":"10.1183\/13993003.00725-2024"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. McCarthy C, Avetisyan R, Carey BC, Chalk C, Trapnell BC. Prevalence and healthcare burden of pulmonary alveolar proteinosis. Orphanet J Rare Dis 13: 129, 2018.","DOI":"10.1186\/s13023-018-0846-y"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Ishii H, Tazawa R, Kaneko C, et al. Clinical features of secondary pulmonary alveolar proteinosis: pre-mortem cases in Japan. Eur Respir J 37: 465-468, 2011.","DOI":"10.1183\/09031936.00092910"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Cordonnier C, Fleury-Feith J, Escudier E, Atassi K, Bernaudin JF. Secondary alveolar proteinosis is a reversible cause of respiratory failure in leukemic patients. Am J Respir Crit Care Med 149: 788-794, 1994.","DOI":"10.1164\/ajrccm.149.3.8118651"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Ishii H. Knowledge of secondary pulmonary alveolar proteinosis complicated with myelodysplastic syndrome. Intern Med 59: 1019-1020, 2020.","DOI":"10.2169\/internalmedicine.4193-19"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Ito Y, Nakahara H, Nakajima A. Development of pulmonary alveolar proteinosis in a patient with adult-onset still disease treated with tocilizumab. J Rheumatol 50: 288-289, 2023.","DOI":"10.3899\/jrheum.220128"},{"key":"13","doi-asserted-by":"publisher","unstructured":"13. Bindoli S, Lococo S, Calabrese F, Sfriso P. Pulmonary alveolar proteinosis in an adult patient affected by Still&apos;s disease and recurrent episodes of macrophage activation syndrome. Joint Bone Spine 91: 105654, 2024.","DOI":"10.1016\/j.jbspin.2023.105654"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Onoda S, Nishino J, Yoshida H, et al. [ANCA-related-vasculitis with pulmonary alveolar proteinosis and hemophagocytic syndrome]. Nihon Naika Gakkai Zasshi (J Jpn Soc Intern Med) 95: 2087-2089, 2006.","DOI":"10.2169\/naika.95.2087"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Ishii H, Seymour JF, Tazawa R, et al. Secondary pulmonary alveolar proteinosis complicating myelodysplastic syndrome results in worsening of prognosis: a retrospective cohort study in Japan. BMC Pulm Med 14: 37, 2014.","DOI":"10.1186\/1471-2466-14-37"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Akasaka K, Tanaka T, Kitamura N, et al. Outcome of corticosteroid administration in autoimmune pulmonary alveolar proteinosis: a retrospective cohort study. BMC Pulm Med 15: 88, 2015.","DOI":"10.1186\/s12890-015-0085-0"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Xie Y, Tolmeijer S, Oskam JM, Tonkens T, Meijer AH, Schaaf MJM. Glucocorticoids inhibit macrophage differentiation towards a pro-inflammatory phenotype upon wounding without affecting their migration. Dis Model Mech 12: dmm037887, 2019.","DOI":"10.1242\/dmm.037887"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Pilavaki M, Smias C, Palladas P. [Secondary pulmonary alveolar proteinosis in an immunosuppressed patient with cytomegalovirus infection]. Arch Bronconeumol 45: 204-205, 2009.","DOI":"10.1016\/S1579-2129(09)71021-3"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Raj D, Bhutia TD, Mathur S, Kabra SK, Lodha R. Pulmonary alveolar proteinosis secondary to <i>Pneumocystis jiroveci<\/i> infection in an infant with common variable immunodeficiency. Indian J Pediatr 81: 929-931, 2014.","DOI":"10.1007\/s12098-013-1027-6"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Raziq FI, Abubaker A, Smith E, Uddin M. Secondary pulmonary alveolar proteinosis in GATA-2 deficiency (MonoMAC syndrome). BMJ Case Rep 13: e238290, 2020.","DOI":"10.1136\/bcr-2020-238290"},{"key":"21","doi-asserted-by":"publisher","unstructured":"21. Wardwell NR Jr., Miller R, Ware LB. Pulmonary alveolar proteinosis associated with a disease-modifying antirheumatoid arthritis drug. Respirology 11: 663-665, 2006.","DOI":"10.1111\/j.1440-1843.2006.00905.x"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Wang S, Lee E, Lau R, Wang T. Sirolimus-induced secondary pulmonary alveolar proteinosis. Respir Med Case Rep 35: 101566, 2022.","DOI":"10.1016\/j.rmcr.2021.101566"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Salvator H, Berti E, Catherinot E, et al.; The Foch Hospital Lung Immune Deficiencies Study Group. Pulmonary alveolar proteinosis and <i>Mycobacterium abscessus<\/i> lung infection related to ruxolitinib after allogeneic stem cell transplantation. Eur Respir J 51: 1701960, 2018.","DOI":"10.1183\/13993003.01960-2017"},{"key":"24","doi-asserted-by":"publisher","unstructured":"24. Hasan A, Ram R, Swamy T. Pulmonary alveolar proteinosis due to mycophenolate and cyclosporine combination therapy in a renal transplant recipient. Lung India 31: 282-284, 2014.","DOI":"10.4103\/0970-2113.135782"},{"key":"25","unstructured":"25. Saper VE, Chen G, Deutsch GH, et al.; Childhood Arthritis and Rheumatology Research Alliance Registry Investigators. Emergent high fatality lung disease in systemic juvenile arthritis. Ann Rheum Dis 78: 1722-1731, 2019."},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Yamasaki M, Kawamoto K, Nakano S, Taniwaki M, Matsumoto N, Hattori N. Secondary pulmonary alveolar proteinosis in a patient with systemic lupus erythematosus. Pulmonology 27: 81-83, 2021.","DOI":"10.1016\/j.pulmoe.2020.07.008"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Silva-D\u00edaz M, Freire Gonz\u00e1lez M, Romero TH. Pulmonary alveolar proteinosis in a patient with systemic lupus erythematosus. J Rheumatol 47: 779-780, 2020.","DOI":"10.3899\/jrheum.181410"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Matsuoka S, Fujiwara K, Takigawa Y, et al. Secondary Pulmonary Alveolar Proteinosis Development during the Treatment for Anti-aminoacyl-tRNA Synthetase Antibody-positive Interstitial Lung Disease. Intern Med 63: 2971-2976, 2024.","DOI":"10.2169\/internalmedicine.3327-23"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Ejaz K, Thalji M, Ali Raza M, Awais H. An unusual case of secondary pulmonary alveolar proteinosis in recently diagnosed anti-MDA5 positive amyopathic dermatomyositis. Am J Med Case Rep 9: 438-440, 2021.","DOI":"10.12691\/ajmcr-9-9-1"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Imura Y, Yukawa N, Handa T, et al. Two cases of autoimmune and secondary pulmonary alveolar proteinosis during immunosuppressive therapy in dermatomyositis with interstitial lung disease. Mod Rheumatol 28: 724-729, 2018.","DOI":"10.3109\/14397595.2016.1153443"},{"key":"31","unstructured":"31. Nitta Y, Yamamoto Y, Hamada E, et al. A case of secondary pulmonary alveolar proteinosis during therapy for interstitial pneumonia associated with anti-MDA5 antibody-positive dermatomyositis. Kikanshigaku (J Jpn Soc Respir Endosc) 44: 228-234, 2022."},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Compa DR, Beegle SH. Wegener granulomatosis and alveolar proteinosis in a 32-year-old female. Chest 132: 687A, 2007.","DOI":"10.1378\/chest.132.4_MeetingAbstracts.687"},{"key":"33","unstructured":"33. Hida N, Yamada H, Mase K, Hizawa N. A case of secondary alveolar proteinosis requiring segmental bronchoalveolar lavage. Kikanshigaku (J Jpn Soc Respir Endosc) 43: 123-128, 2021."},{"key":"34","doi-asserted-by":"crossref","unstructured":"34. Shimizu H, Sato S, Suzuki T, et al. Intestinal Beh\u00e7et&apos;s disease complicated by myelodysplastic syndrome and secondary pulmonary alveolar proteinosis: a case report. BMC Gastroenterol 21: 488, 2021.","DOI":"10.1186\/s12876-021-02065-0"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35. Handa T, Nakatsue T, Baba M, Takada T, Nakata K, Ishii H. Clinical features of three cases with pulmonary alveolar proteinosis secondary to myelodysplastic syndrome developed during the course of Beh\u00e7et&apos;s disease. Respir Investig 52: 75-79, 2014.","DOI":"10.1016\/j.resinv.2013.05.005"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36. Tetikkurt C, Tetikkurt S, Ozdemir I, Zuhur C, Bayar N. Alveolar proteinosis in Beh\u00e7et&apos;s disease. Multidiscip Respir Med 5: 264-266, 2010.","DOI":"10.1186\/2049-6958-5-4-264"},{"key":"37","doi-asserted-by":"publisher","unstructured":"37. Uchiyama M, Nagao T, Hattori A, et al. Pulmonary alveolar proteinosis in a patient with Behcet&apos;s disease. Respirology 14: 305-308, 2009.","DOI":"10.1111\/j.1440-1843.2008.01450.x"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/65\/2\/65_5421-25\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,17]],"date-time":"2026-01-17T03:32:46Z","timestamp":1768620766000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/65\/2\/65_5421-25\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,15]]},"references-count":37,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.5421-25","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,15]]},"article-number":"5421-25"}}